These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 7438124)

  • 1. Vindesine in the treatment of small cell and non-small cell bronchogenic carcinoma: preliminary results.
    Mattson K; Holsti LR; Salmo M; Saastamoinen M; Ahlstedt S; Holsti P
    Cancer Treat Rev; 1980 Sep; 7 Suppl 1():65-70. PubMed ID: 7438124
    [No Abstract]   [Full Text] [Related]  

  • 2. Vindesine chemotherapy in lung cancer.
    Natale RB; Gralla RJ; Wittes RE; Golbey RB; Young CW
    Cancer Treat Rev; 1980 Sep; 7 Suppl 1():59-63. PubMed ID: 7438123
    [No Abstract]   [Full Text] [Related]  

  • 3. Vindesine in the treatment of small cell anaplastic bronchogenic carcinoma.
    Osterlind K; Dombernowsky P; Sørensen PG; Hansen HH
    Cancer Treat Rep; 1981; 65(3-4):245-8. PubMed ID: 6263469
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Phase II study of vindesine in patients with primary bronchogenic carcinoma by Cooperative Study Group].
    Gan To Kagaku Ryoho; 1983 Aug; 10(8):1838-43. PubMed ID: 6882007
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Antineoplastic chemotherapy for bronchial carcinoma].
    Tanneberger S
    Arch Geschwulstforsch; 1985; 55(1):63-71. PubMed ID: 2985017
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combination chemotherapy of small-cell bronchogenic carcinoma with etoposide (VP-16), ifosfamide and vindesine (VPIV), and with adriamycin, cis-platinum and vincristine (APO).
    Havemann K
    Cancer Treat Rev; 1982 Jun; 9 Suppl():95-100. PubMed ID: 6290059
    [No Abstract]   [Full Text] [Related]  

  • 7. Vindesine in bronchogenic carcinoma: a phase II trial.
    Vogelzang NJ; Peterson BA; Kennedy BJ; Vosika GJ; Conroy JA
    Am J Clin Oncol; 1982 Feb; 5(1):41-4. PubMed ID: 6282107
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phase II evaluation of vindesine in non-small cell bronchogenic carcinoma.
    Hutcheon AW; Palmer JB; Pratt MA; Clark RA
    Cancer Treat Rep; 1983 Nov; 67(11):1041-2. PubMed ID: 6315231
    [No Abstract]   [Full Text] [Related]  

  • 9. [Chemotherapy of advanced non-small cell bronchogenic carcinoma with cisplatin and vindesine].
    Drings P; Kleckow M; Manke HG; Stiefel E
    Onkologie; 1984 Aug; 7(4):202-4. PubMed ID: 6384861
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chemotherapy for lung cancer at the Institute of Experimental and Clinical Oncology, Academy of Medical Sciences, USSR.
    Perevodchikova NI; Bychkov MB
    Cancer Chemother Rep 3; 1973 Mar; 4(2):251-5. PubMed ID: 4199645
    [No Abstract]   [Full Text] [Related]  

  • 11. Mitomycin-associated lung disease.
    Gunstream SR; Seidenfeld JJ; Sobonya RE; McMahon LJ
    Cancer Treat Rep; 1983 Mar; 67(3):301-4. PubMed ID: 6187452
    [No Abstract]   [Full Text] [Related]  

  • 12. Chemotherapeutic studies in bronchogenic carcinoma by the Austrian study group.
    Karrer K; Pridun N; Zwintz E
    Cancer Chemother Rep 3; 1973 Mar; 4(2):207-13. PubMed ID: 4729324
    [No Abstract]   [Full Text] [Related]  

  • 13. Combination chemotherapy with cyclophosphamide, vincristine, methyl-CCNU, and bleomycin in advanced bronchogenic carcinoma: experience with 106 patients.
    Samson MK; Baker LH; Fraile RJ; Izbicki RM; Vaitkevicius VK
    Cancer Treat Rep; 1977; 61(1):59-64. PubMed ID: 67895
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combination chemotherapy of bronchogenic carcinoma. I. Non-oat cell.
    Livingston RB
    Cancer Treat Rev; 1977 Sep; 4(3):153-65. PubMed ID: 73419
    [No Abstract]   [Full Text] [Related]  

  • 15. [After care in bronchial carcinoma. Results of postoperative polychemotherapy].
    Karrer K; Pridun N; Denck H
    Fortschr Med; 1976 Mar; 94(7):379-85. PubMed ID: 184021
    [No Abstract]   [Full Text] [Related]  

  • 16. Chemotherapy of bronchogenic carcinomas by a combination of cyclophosphamide, methotrexate, vincristin and bleomycin.
    Schaerer R; Sotto JJ; Wiget U; Perdrix A; Bensa JC; Ribaud P
    Eur J Cancer (1965); 1977; 13(4-5):425-8. PubMed ID: 68881
    [No Abstract]   [Full Text] [Related]  

  • 17. [Bronchial cancer: possibilities and limits of chemotherapy. 2: Non-small cell bronchial cancer].
    Schalhorn A
    Fortschr Med; 1985 May; 103(17):453-6. PubMed ID: 4039699
    [No Abstract]   [Full Text] [Related]  

  • 18. A comparison of the response of human lung carcinoma xenografts to vindesine and vincristine.
    Evans BD; Smith IE; Shorthouse AJ; Millar JL
    Br J Cancer; 1982 Mar; 45(3):466-8. PubMed ID: 6280742
    [No Abstract]   [Full Text] [Related]  

  • 19. [Prognostic factors in the chemotherapy of bronchial cancers].
    Alberto P
    Schweiz Med Wochenschr; 1974 Feb; 104(8):268-71. PubMed ID: 4360755
    [No Abstract]   [Full Text] [Related]  

  • 20. New agents and combinations in the treatment of bronchogenic carcinoma.
    Bodey GP; Gottlieb JA; Livingston R; Frei E
    Cancer Chemother Rep 3; 1973 Mar; 4(2):227-9. PubMed ID: 4125740
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.